🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/05/2016 | 74,80 | 76,70 | 74,47 | 75,83 | +2,00% | 2,98% | 661.558 |
| 06/05/2016 | 73,24 | 74,38 | 71,45 | 74,34 | +0,79% | 4,00% | 641.360 |
| 05/05/2016 | 75,17 | 75,39 | 72,76 | 73,76 | -1,79% | 3,50% | 705.480 |
| 04/05/2016 | 77,66 | 77,70 | 73,59 | 75,10 | +0,41% | 5,30% | 1.009.089 |
| 03/05/2016 | 76,12 | 76,34 | 74,39 | 74,80 | -2,54% | 2,56% | 788.676 |
| 02/05/2016 | 76,03 | 76,89 | 74,67 | 76,74 | +1,78% | 2,92% | 609.781 |
| 29/04/2016 | 76,82 | 77,14 | 74,42 | 75,40 | -1,83% | 3,54% | 672.939 |
| 28/04/2016 | 77,22 | 78,84 | 76,48 | 76,81 | -0,69% | 3,05% | 818.171 |
| 27/04/2016 | 78,40 | 78,40 | 76,51 | 77,34 | -1,66% | 2,41% | 956.670 |
| 26/04/2016 | 81,15 | 81,37 | 78,35 | 78,64 | -3,11% | 3,72% | 749.082 |
| 25/04/2016 | 81,10 | 81,65 | 79,85 | 81,17 | -0,06% | 2,22% | 724.716 |
| 22/04/2016 | 81,15 | 82,25 | 79,38 | 81,22 | -0,14% | 3,54% | 530.112 |
| 21/04/2016 | 80,29 | 81,65 | 79,15 | 81,33 | +1,77% | 3,12% | 716.060 |
| 20/04/2016 | 80,31 | 80,57 | 79,36 | 79,91 | +0,12% | 1,51% | 696.183 |
| 19/04/2016 | 79,35 | 79,85 | 78,09 | 79,82 | +1,27% | 2,22% | 692.977 |
| 18/04/2016 | 77,57 | 78,95 | 77,04 | 78,81 | +1,40% | 2,46% | 748.761 |
| 15/04/2016 | 77,50 | 78,20 | 76,46 | 77,72 | +0,47% | 2,25% | 620.842 |
| 14/04/2016 | 76,32 | 77,45 | 75,05 | 77,36 | +2,13% | 3,16% | 893.352 |
| 13/04/2016 | 74,77 | 76,73 | 74,14 | 75,75 | +3,06% | 3,46% | 1.216.998 |
| 12/04/2016 | 71,73 | 73,59 | 71,22 | 73,49 | +2,26% | 3,30% | 925.733 |
| 11/04/2016 | 72,99 | 72,99 | 71,09 | 71,87 | -0,92% | 2,62% | 419.826 |
| 08/04/2016 | 73,17 | 73,31 | 70,56 | 72,54 | -0,01% | 3,75% | 618.918 |
| 07/04/2016 | 72,69 | 73,95 | 71,49 | 72,55 | -0,84% | 3,38% | 642.803 |
| 06/04/2016 | 69,45 | 73,22 | 69,45 | 73,16 | +5,71% | 5,43% | 730.167 |
| 05/04/2016 | 69,21 | 70,17 | 68,66 | 69,21 | -0,64% | 2,18% | 445.955 |
| 04/04/2016 | 69,25 | 71,08 | 68,97 | 69,65 | +0,69% | 3,04% | 489.556 |
| 01/04/2016 | 66,29 | 69,53 | 66,08 | 69,17 | +3,54% | 5,21% | 542.776 |
| 31/03/2016 | 65,80 | 67,87 | 65,60 | 66,81 | +2,03% | 3,45% | 649.536 |
| 30/03/2016 | 65,50 | 67,06 | 64,38 | 65,48 | +0,10% | 4,09% | 493.083 |
| 29/03/2016 | 63,67 | 65,49 | 63,10 | 65,41 | +2,27% | 3,75% | 592.789 |